Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 7 studies | 32% ± 12% | |
| macrophage | 7 studies | 25% ± 10% | |
| ciliated cell | 5 studies | 24% ± 6% | |
| microglial cell | 5 studies | 30% ± 9% | |
| myeloid cell | 4 studies | 18% ± 2% | |
| glutamatergic neuron | 3 studies | 31% ± 4% | |
| astrocyte | 3 studies | 34% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 32% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 1508.60 | 245 / 245 | 98% | 15.25 | 490 / 502 |
| lung | 99% | 1390.29 | 572 / 578 | 99% | 10.69 | 1139 / 1155 |
| kidney | 99% | 1130.57 | 88 / 89 | 97% | 13.07 | 876 / 901 |
| thymus | 98% | 783.37 | 639 / 653 | 98% | 8.41 | 594 / 605 |
| adrenal gland | 100% | 3703.93 | 258 / 258 | 93% | 15.18 | 214 / 230 |
| brain | 95% | 1287.57 | 2523 / 2642 | 96% | 9.56 | 680 / 705 |
| stomach | 93% | 686.09 | 333 / 359 | 95% | 7.30 | 273 / 286 |
| intestine | 84% | 811.46 | 814 / 966 | 98% | 7.59 | 516 / 527 |
| esophagus | 84% | 746.01 | 1216 / 1445 | 95% | 9.88 | 174 / 183 |
| bladder | 81% | 826.52 | 17 / 21 | 95% | 7.56 | 481 / 504 |
| breast | 75% | 490.09 | 346 / 459 | 97% | 7.98 | 1080 / 1118 |
| uterus | 78% | 608.44 | 133 / 170 | 92% | 9.33 | 423 / 459 |
| skin | 100% | 1915.60 | 1801 / 1809 | 68% | 4.24 | 323 / 472 |
| ovary | 66% | 429.58 | 119 / 180 | 89% | 5.19 | 384 / 430 |
| pancreas | 58% | 294.40 | 189 / 328 | 97% | 9.23 | 173 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 21.36 | 29 / 29 |
| spleen | 100% | 2341.08 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.34 | 1 / 1 |
| muscle | 100% | 8051.08 | 800 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 2675.19 | 917 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 18.90 | 44 / 45 |
| adipose | 87% | 714.84 | 1044 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 39% | 1.33 | 31 / 80 |
| blood vessel | 38% | 258.53 | 501 / 1335 | 0% | 0 | 0 / 0 |
| heart | 37% | 191.90 | 316 / 861 | 0% | 0 | 0 / 0 |
| liver | 7% | 38.31 | 16 / 226 | 28% | 1.58 | 112 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006188 | Biological process | IMP biosynthetic process |
| GO_0032264 | Biological process | IMP salvage |
| GO_0046033 | Biological process | AMP metabolic process |
| GO_0006196 | Biological process | AMP catabolic process |
| GO_0034774 | Cellular component | secretory granule lumen |
| GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
| GO_0005829 | Cellular component | cytosol |
| GO_0005576 | Cellular component | extracellular region |
| GO_0003876 | Molecular function | AMP deaminase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | AMPD3 |
| Protein name | AMP deaminase (EC 3.5.4.6) Adenosine monophosphate deaminase 3 AMP deaminase 3 (EC 3.5.4.6) (AMP deaminase isoform E) (Erythrocyte AMP deaminase) |
| Synonyms | |
| Description | FUNCTION: AMP deaminase plays a critical role in energy metabolism. . |
| Accessions | ENST00000532250.5 Q01432 ENST00000396554.7 [Q01432-4] ENST00000396553.7 [Q01432-1] ENST00000528723.5 [Q01432-5] H0YDY8 E9PPG2 ENST00000524866.5 ENST00000529507.5 [Q01432-1] ENST00000533116.1 ENST00000529744.1 ENST00000534047.5 H0YDC3 ENST00000529834.5 E9PIR5 E9PLK6 ENST00000444303.6 [Q01432-6] E9PKC5 |
